Quantcast

Latest Bayer Schering Pharma Stories

2010-11-29 08:28:00

WARRENDALE, Pa., Nov. 29, 2010 /PRNewswire/ -- MEDRAD, Inc. a business of Bayer HealthCare, today announces the U.S. launch of VirtualCARE®, for the MEDRAD Intego(TM) PET Infusion System. VirtualCARE is a technology platform that allows MEDRAD to remotely support maintenance and system updates securely over the internet. (Logo: http://photos.prnewswire.com/prnh/20040309/MEDRADLOGO ) MEDRAD is the first company in the U.S. to offer remote service and system support for an...

2010-11-17 11:48:00

WARRENDALE, Pa., Nov. 17, 2010 /PRNewswire/ -- MEDRAD will offer RSNA* attendees hands-on demonstrations of personalized-protocol software that individualizes CT Pulmonary Angiography (CTPA) contrast dosing, and has proven to increase the percentage of diagnostic-quality studies to rule out Pulmonary Embolism (PE) when compared to the institution's standard protocol(1)** -- potentially obviating the need to rescan the patient.(2) Diagnosis with a high degree of certainty is critical to...

2010-09-30 00:00:00

NEW YORK, Sept. 30 /PRNewswire/ -- The Prix Galien USA committee honored innovations that are saving lives last night during the Prix Galien Awards Gala. The Pro Bono Humanum Award, the Prix Galien USA 2010 and the Prix Galien International were presented and related accomplishments celebrated. The 11 members committee among them 7 Nobel laureates conferred its Pro Bono Humanum Award to Philippe Douste-Blazy, M.D., President of UNITAID, and President Bill Clinton, founder of the William...

2010-09-17 07:00:00

WARRENDALE, Pa., Sept. 17 /PRNewswire/ -- At MEDRAD, Inc., community outreach is a celebrated corporate tradition. This year marks MEDRAD's 11th annual Day of Caring, a company-sponsored event where employees will have the opportunity to spend a workday volunteering in their communities. (Logo: http://photos.prnewswire.com/prnh/20040309/MEDRADLOGO ) (Logo: http://www.newscom.com/cgi-bin/prnh/20040309/MEDRADLOGO ) Over 1000 MEDRAD employees will participate in the event this year,...

2010-09-09 07:30:00

WALTHAM, Mass., Sept. 9 /PRNewswire/ -- Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, today announced that Joanna Horobin, M.D., the company's president and CEO, will present an overview of upcoming milestones including the ongoing phase 2 clinical program for entinostat in breast, lung, colorectal cancer and hematologic malignancies, at the following conferences: R.W. Baird 2010 Healthcare Conference New York, NY Wednesday, September 15, 2010...

2010-06-17 03:00:00

REDWOOD CITY, Calif., June 17 /PRNewswire/ -- OncoMed Pharmaceuticals, Inc. and Bayer Schering Pharma AG, Germany, today announced a global strategic alliance to discover, develop and commercialize novel anti-cancer stem cell therapeutics targeting the Wnt signaling pathway. Cancer stem cells are a subset of tumor cells believed to play a significant role in the establishment, metastasis and recurrence of cancer. The strategic alliance leverages OncoMed's leadership in cancer stem...

2010-05-21 11:55:00

WELLESLEY HILLS, Mass., May 21 /PRNewswire/ -- Joseph F. Finn, Jr., C.P.A. ("Finn"), Assignee for the Benefit of Creditors of Epix Pharmaceuticals, Inc. ("Epix"), announced today that the auction of the MRI imaging intellectual properties has been changed to June 22, 2010 at 9:00 A.M. Eastern. This was done to allow bidders to complete due diligence on all three (3) gadolinium-based imaging programs. They consist of 1) MS-325 (gadofosveset trisodium), commercial MRA imaging agent,...

2010-05-19 09:46:00

WARRENDALE, Pa., May 19 /PRNewswire/ -- Today, MEDRAD, Inc. and Pinestar Technology, Inc. announced plans to enable data communication between MEDRAD's Intego(TM) PET Infusion System and Pinestar's Nuclear Medicine Information System (NMIS). The companies are closing the information gap between state of the art infusion systems and the latest information systems, and thus adding to the workflow benefits of automated FDG infusion. The data integration capability can be previewed at the...

2010-04-21 07:55:00

BETHESDA, Md., April 21 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI) a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, announced today that it has achieved a milestone under its collaboration agreement with Bayer Schering Pharma AG. The milestone was triggered by Micromet's achievement of pre-clinical proof of concept for a BiTE antibody for the treatment of solid tumors. "We have made...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related